SCHEMBL4127746

SCHEMBL4127746

O=C(O)Cc1csc(NC2=NC(=O)C(=Cc3cc4ccccc4cc3OCc3ccccc3)S2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTP4A3 O75365 3/20 0.48
GAA P10253 4/20 0.41
MAPT P10636 4/20 0.41
GCK P35557 2/20 0.40
PTGER1 P34995 2/20 0.39
ALDH1A1 P00352 4/20 0.39
PTPN1 P18031 1/20 0.38
CGAS Q8N884 1/20 0.38
CISD1 Q9NZ45 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
TTR P02766 1/20 0.37
BLM P54132 1/20 0.37
NPC1 O15118 1/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
PLA2G1B P04054 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4127740 1.00 PTP4A3 (0.48) PTP4A3GAAMAPTGCKPTGER1
SCHEMBL4125733 0.85 PTP4A3 (0.50) PTP4A3ALDH1A1PTPN1CISD1MEN1
SCHEMBL4125736 0.85 PTP4A3 (0.50) PTP4A3ALDH1A1PTPN1CISD1MEN1
SCHEMBL4133685 0.84 PTP4A3 (0.49) PTP4A3ALDH1A1PTPN1CISD1MEN1
SCHEMBL4133682 0.84 PTP4A3 (0.49) PTP4A3ALDH1A1PTPN1CISD1MEN1
SCHEMBL4131690 0.80 MEN1 (0.45) PTP4A3PTPN1CISD1MEN1KMT2A
SCHEMBL4131686 0.80 MEN1 (0.45) PTP4A3PTPN1CISD1MEN1KMT2A
SCHEMBL4137639 0.80 PTP4A3 (0.51) PTP4A3PTPN1CISD1POLB
SCHEMBL4137638 0.80 PTP4A3 (0.51) PTP4A3PTPN1CISD1POLB
Propionic Acid SCHEMBL4133739 0.79 PTP4A3 (0.47) PTP4A3ALDH1A1PTPN1CISD1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US claimed
EP-1934192-A1 THIAZOLINONES AND OXAZOLINONES AND THEIR USE AS PTP1B INHIBITORS Torrent Pharmaceuticals Ltd (IN) 2008-06-25 EP claimed
WO-2007032028-A1 THIAZOLINONES AND OXAZOLINONES AND THEIR USE AS PTP1B INHIBITORS TORRENT PHARMACEUTICALS LTD. (IN) 2007-03-22 WO claimed
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors PTPRF, PTPA, PTPRJ PTP4A3 26/4885GAA 387/4885MAPT 3532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.